Skip to main content
close menu
close menu

Search UK HealthCare

Menu
Open search dialog Magnifying Glass My UK HealthCare

FLU RESTRICTIONS

× Close Visitation restrictions now in effect. Learn more Arrow Pointing Right

Stephen E. Strup, MD, FACS

Chairman, Department of Urologic Surgery
Stephen E. Strup, MD, FACS
best doctor logo
Request an Appointment Physician Referral

Specialties

  • Genitourinary and Prostate Cancer Team
  • Living Donor Kidney Transplant
  • Urology

  • About

    Stephen E. Strup is the James F. Glenn Professor and Chairman of Urology at the University of Kentucky. He is a native of Northwest Ohio and attended DePauw University, graduating Summa Cum Laude in 1984. He received his medical degree from the University of Indiana in 1988. He completed a residency in Urology in 1994 at Thomas Jefferson University in Philadelphia and then completed an Urologic oncology fellowship in 1996 at the National Cancer Institute in Bethesda, Maryland. He returned to Thomas Jefferson University where he was one of the early adopters of the Hand-assisted laparoscopic nephrectomy and laparoscopic radical prostatectomy techniques.

    In 2003, Dr. Strup moved to the University of Kentucky in Lexington, where he was appointed the Director of Minimally invasive urologic surgery and, in 2006, residency program director. He was then named the James F. Glenn Chief of Urology in 2007. His clinical interests include Urologic Oncology, minimally invasive and robotic surgery, and living donor nephrectomy.

    Faculty Rank

    Professor of Urology

    Degree

    Indiana University, School of Medicine, Indianapolis

    Residency

    Jefferson Medical College, Philadelphia

    Fellowship

    National Institutes of Health-National Cancer Institute, Bethesda, Md.

    Certifications and Special Training

    American Board of Urology

    Fellow of the American College of Surgeons

  • Publications

    Publications

    1. Reversion of epithelial-mesenchymal transition by a novel agent DZ-50 via IGF binding protein-3 in prostate cancer cells. Cao, Z.;Koochekpour, S.;Strup, S.E.;Kyprianou, N. Oncotarget 8, 45 (2017): 78507-78519.
    2. Reversion of epithelial-mesenchymal transition by a novel agent DZ-50 via IGF binding protein-3 in prostate cancer cells. Cao, Z.;Koochekpour, S.;Strup, S.E.;Kyprianou, N. Oncotarget (2017)
    3. Association of epithelial-mesenchymal transition and nuclear cofilin with advanced urothelial cancer. Hensley, P.J.;Zetter, D.;Horbinski, C.M.;Strup, S.E.;Kyprianou, N. Human pathology 57, (2016): 68-77.
    4. Trends in the management of male urethral stricture disease in the veteran population. Lacy, J.M.;Cavallini, M.;Bylund, J.R.;Strup, S.E.;Preston, D.M. Urology 84, 6 (2014): 1506-9.
    5. Association of clinical and radiographic features with perinephric "sticky" fat. Bylund, J.R.;Qiong, H.;Crispen, P.L.;Venkatesh, R.;Strup, S.E. Journal of endourology 27, 3 (2013): 370-3.